Neural targets are read in tissue far more often than on a blot, so the reagent is chosen for a section rather than for a membrane, and the fixation and retrieval decide whether the epitope is there at all. Most of these antibodies are also markers, which means the question is whether a stain identifies the cell type claimed rather than whether a band is the right size.
A synapsin i antibody and an mbp antibody on synapses and myelin
Both are abundant structural proteins, which makes them forgiving on a blot and demanding in a section. Synaptic vesicle proteins give a punctate pattern that is the control: a diffuse stain means over-fixation, too much antibody or a failed permeabilisation. Myelin basic protein is extremely abundant and highly charged, so it is prone to background and to edge artefacts, and it survives harsh processing well enough that a weak stain usually means retrieval rather than antigen loss. For either, a known positive region in the same section settles it.
A brn3a antibody and a ctip2 antibody on lineage transcription factors
Lineage factors are nuclear, low abundance and read as the identity of a cell, so the whole value of the reagent is whether the nuclei it marks are the population claimed. That needs a documented pattern in the tissue, a counterstain, and ideally a second marker of the same lineage, because a plausible nuclear stain is the easiest artefact in immunohistochemistry to accept. Retrieval is usually heat and citrate or EDTA, and the two give different results, so the buffer belongs in the method.
An rpe65 antibody and an eaat1 antibody on retina and transporters
The retinal isomerase is confined to the pigment epithelium, which makes it a strict layer marker and a good internal control: if the stain is anywhere else, something is wrong. The glutamate transporter is a multipass membrane protein expressed on glia, with the difficulties that class always brings, so the honest readings are membrane-associated staining in a known glial population and a blot run without boiling. Both are also used in gene therapy work, where the question is transduced cells rather than total signal.
A trkb antibody and an acetylcholinesterase antibody on receptors and enzymes
The neurotrophin receptor exists as a full length kinase and a truncated form that lacks the kinase domain, and a clone raised against the intracellular region sees only the full length protein, which changes every conclusion about receptor abundance. Phospho-specific clones against named residues are what measure activation, with a ligand-stimulated positive control. The esterase is secreted and membrane anchored in several forms, so the fraction measured has to be stated, and activity assays remain the more quantitative readout.
Fixation and retrieval, the two decisions behind most failures
For neural tissue the pairing that works is usually four per cent paraformaldehyde with a cryoprotection step for free floating sections, or formalin fixation with paraffin and heat retrieval for archival material, and a clone validated on one is not validated on the other. Over-fixation masks epitopes and is recovered, imperfectly, by longer retrieval; under-fixation loses morphology permanently. Where a marker matters, run a fixation and retrieval matrix once on control tissue and record the winning combination with the clone.
Marker panels rather than single stains
A cell type is identified by a combination: a lineage transcription factor plus a functional enzyme, or a structural protein plus a transporter, imaged in channels that do not bleed. That is more work than one stain and it is what makes the claim survive review, because every single marker in this list appears in more than one population somewhere in the nervous system. Panel design starts from the negative population you must exclude rather than from the positive one you hope to see.
Questions people ask about tyrosine hydroxylase antibody
Why does the same clone work in one laboratory and not another?
Usually fixation and retrieval. A clone validated on cryosections is not validated on paraffin, and over-fixation masks epitopes that longer retrieval only partly recovers.
How is a lineage marker validated?
By a documented pattern in the tissue plus a second marker of the same population. A plausible nuclear stain on its own is the easiest artefact to accept.
Which TrkB antibody reports total receptor?
One whose immunogen lies outside the kinase domain. A clone raised against the intracellular region misses the truncated isoform entirely.